Innovative Aerosystems (NASDAQ:ISSC) has reached an agreement with Honeywell International (NASDAQ:HON) to acquire key assets and intellectual property for select legacy avionics lines, a move that deepens the company’s reach into the global general aviation market.
Classover (NASDAQ:KIDZ), an AI-powered education technology company, reported its full-year 2025 financial results.
Lindsay (NYSE:LNN) reported a sharp decline in second-quarter profitability as a contraction in both its agricultural and infrastructure segments weighed on the top line, leading to a more than 50% drop in net earnings.
Trimble (NASDAQ:TRMB) has moved to deepen its artificial intelligence capabilities within the construction sector, announcing an agreement to acquire Document Crunch, a provider of AI-powered contract intelligence and risk management tools.
AirSculpt Technologies (NASDAQ:AIRS), a national provider of body contouring procedures, reported its fourth-quarter and full-year fiscal 2025 financial results.
Acuity Brands (NYSE:AYI) reported a surge in second-quarter profitability and rewarded shareholders with an 18% dividend hike, as the company’s expansion into intelligent infrastructure compensated for a leaner performance in its core lighting segment.
Faraday Future Intelligent Electric (NASDAQ:FFAI) announced its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, April 2, 2026.
Target Hospitality (NASDAQ:TH) announced on Wednesday, April 1, 2026, a transformative multi-year lease and services agreement to support a "top-five" global hyperscaler in the development of a massive data center campus in North Texas.
Penguin Solutions (NASDAQ:PENG) reported its financial results for the second quarter of fiscal 2026 on Wednesday, April 1.
RenX Enterprises (NASDAQ:RENX) announced its financial results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.
SES AI (NYSE:SES), a global leader in the development and manufacturing of AI-enhanced high-performance lithium-metal and lithium-ion batteries, provided a robust business update for the first quarter of 2026 on Wednesday, April 1.
Scinai Immunotherapeutics (NASDAQ:SCNI) reported its financial and operational results for the fiscal year ended December 31, 2025, on Wednesday, April 1, 2026.
